# Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

> **NCT01625494** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 158 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan/Amlodipine (150/5mg)
- **DRUG:** Irbesartan/Amlodipine (150/10mg)
- **DRUG:** Irbesartan/Amlodipine (300/5mg)
- **DRUG:** Irbesartan/Amlodipine (300/10mg)

## Key facts

- **NCT ID:** NCT01625494
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2013-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625494, "Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01625494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*